Bioterrorism-related Inhalational Anthrax in an Elderly Woman, Connecticut, 2001
Kevin S. Griffith*† , Paul S. Mead*, Gregory L. Armstrong*, John Painter*, Katherine A. Kelley†, Alex R. Hoffmaster*, Donald Mayo†, Diane Barden†, Renee Ridzon*, Umesh Parashar*, Eyasu Habtu Teshale*, Jen Williams*, Stephanie Noviello*‡, Joseph F. Perz*, Eric E. Mast*, David L. Swerdlow*, and James L. Hadler†
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Connecticut Department of Public Health, Hartford, Connecticut, USA; ‡New York State Department of Health, Albany, New York, USA
Figure 1. Bioterrorism-related inhalational anthrax cases by week of symptom onset—United States, 2001.The first two cases of inhalational anthrax occurred in Florida. Though no direct exposure source was found, environmental samples of the media company in which these two patients worked and the postal facilities serving the media company yielded Bacillus anthracis spores specifically implicating a B. anthracis–containing letter or package (4): †, the letters to Senators Thomas Daschle and Patraick Leahy were postmarked in the Trenton, New Jersey, processing and distribution center on October 9, 2001; black bars indicate cases of inhalational anthrax in persons with direct exposure to a B. anthracis–containing letter; gray bars indicate cases of inhalational anthrax persons with no known B. anthracis exposure.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.